Genomic signaling of vitamin D

It took several hundred million years of evolution, in order to develop the endocrine vitamin D signaling system, which is formed by a nuclear receptor, the transcription factor VDR (vitamin D receptor), its ligand, the vitamin D3 metabolite 1 & alpha;,25-dihydroxyvitamin D3 (1,25(OH)2D3) and several metabolizing enzymes and transport proteins. Even within the nuclear receptor superfamily the affinity of VDR for 1,25(OH)2D3 is outstandingly high (KD = 0.1 nM). The activation of VDR by 1,25(OH)2D3 is the core mechanism of genomic signaling of vitamin D3, which results in the modulation of the epigenome at thousands of promoter and enhancer regions as well as finally in the activation or repression of hundreds of target gene transcription. In addition, rapid non-genomic actions of vitamin D are described, which are mechanistically far less understood. The main function of vitamin D is to keep the human body in homeostasis. This implies the control of calcium levels, which is essential for bone mineralization, as well as for pushing of innate immunity to react sufficiently strong to microbe infection and preventing overreactions of adaptive immunity, i.e., not to cause autoimmune diseases. This review will discuss whether genomic signaling is sufficient for explaining all physiological functions of vitamin D3.

Automated summary

It took millions of years of evolution to develop the endocrine vitamin D signaling system, which includes the nuclear receptor VDR, its ligand 1,25(OH)2D3, and metabolizing enzymes and transport proteins. The activation of VDR by 1,25(OH)2D3 is the core mechanism of genomic signaling, resulting in modulation of the epigenome and transcription of target genes. Vitamin D plays a critical role in maintaining homeostasis, regulating calcium levels for bone mineralization and immune responses. This review will discuss if genomic signaling is sufficient to explain all physiological functions of vitamin D3.